Published in HPB (Oxford) on June 07, 2011
Standard of Care Versus Hemopatch® During Liver Resection (IBERLIVER) | NCT03166683
External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage. HPB (Oxford) (2016) 1.12
Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma. J Am Coll Surg (2016) 1.10
HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03
Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) (2012) 0.96
Factors in perioperative care that determine blood loss in liver surgery. HPB (Oxford) (2012) 0.93
Prospective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study. HPB (Oxford) (2014) 0.92
Laparoscopic versus open major hepatectomy for hepatocellular carcinoma: a matched pair analysis. Surg Endosc (2015) 0.89
Influence of body mass index on postoperative outcomes after laparoscopic liver resection. Surg Endosc (2015) 0.85
Preoperative endoscopic versus percutaneous transhepatic biliary drainage in potentially resectable perihilar cholangiocarcinoma (DRAINAGE trial): design and rationale of a randomized controlled trial. BMC Gastroenterol (2015) 0.84
Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives. World J Gastrointest Surg (2013) 0.83
Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma. HPB (Oxford) (2015) 0.83
Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial. BMC Cancer (2014) 0.82
Laparoscopic surgery of liver tumors. Langenbecks Arch Surg (2013) 0.82
Outcome after a liver resection of benign lesions. HPB (Oxford) (2015) 0.81
Use of pre-operative steroids in liver resection: a systematic review and meta-analysis. HPB (Oxford) (2013) 0.80
Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg (2013) 0.80
Pure laparoscopic liver resection reduces surgical site infections and hospital stay. Results of a case-matched control study in 50 patients. Langenbecks Arch Surg (2014) 0.79
Impact of early reoperation following living-donor liver transplantation on graft survival. PLoS One (2014) 0.78
Clamp-crushing versus stapler hepatectomy for transection of the parenchyma in elective hepatic resection (CRUNSH)--a randomized controlled trial (NCT01049607). BMC Surg (2011) 0.78
Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models. HPB (Oxford) (2014) 0.78
Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford) (2013) 0.77
IMMEDIATE COMPLICATIONS AFTER 88 HEPATECTOMIES - BRAZILIAN CONSECUTIVE SERIES. Arq Bras Cir Dig (2016) 0.77
Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models. ISRN Surg (2014) 0.77
Incidence, risk factors and consequences of bile leakage following laparoscopic major hepatectomy. Surg Endosc (2015) 0.77
Central Hepatectomy versus Extended Hepatectomy for Malignant Tumors: A Propensity Score Analysis of Postoperative Complications. World J Surg (2016) 0.76
A multicentre retrospective study of transcatheter angiographic embolization in the treatment of delayed haemorrhage after percutaneous nephrolithotomy. Eur Radiol (2014) 0.76
Complications following liver resection for colorectal metastases do not impact on longterm outcome. HPB (Oxford) (2014) 0.76
Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases. BMC Cancer (2016) 0.75
Efficacy of Oxidized Regenerated Cellulose, SurgiGuard®, in Porcine Surgery. Yonsei Med J (2017) 0.75
Metabolic signature of electrosurgical liver dissection. PLoS One (2013) 0.75
BiClamp® forcep liver transection versus clamp crushing technique for liver resection: study protocol for a randomized controlled trial. Trials (2015) 0.75
Risk factors for a high Comprehensive Complication Index score after major hepatectomy for biliary cancer: a study of 229 patients at a single institution. HPB (Oxford) (2016) 0.75
Early Experience with a Hepatobiliary and Pancreatic Quality Improvement Program. BMJ Qual Improv Rep (2013) 0.75
Post-hepatectomy haemorrhage: a single-centre experience. HPB (Oxford) (2014) 0.75
Local venous thrombotic risk of an expanding haemostatic agent used during liver resection. World J Surg (2014) 0.75
Retrograde laparoscopic resection of left side of the liver: a safe and effective way. Surg Endosc (2015) 0.75
Prospective Validation of Optimal Drain Management "The 3 × 3 Rule" after Liver Resection. World J Surg (2016) 0.75
Operation Start Times and Postoperative Morbidity from Liver Resection: A Propensity Score Matching Analysis. World J Surg (2016) 0.75
Risk factors for acute kidney injury after partial hepatectomy. World J Hepatol (2017) 0.75
Effects of postoperative morbidity on long-term outcome following surgery for colorectal liver metastases. World J Surg (2015) 0.75
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery (2005) 16.42
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery (2007) 6.62
Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg (2000) 5.79
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery (2007) 4.72
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg (1994) 4.24
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg (2003) 3.14
Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg (1998) 2.97
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery (1994) 2.45
Solid liver tumors. Major Probl Clin Surg (1977) 2.42
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery (2006) 2.24
Delayed massive hemorrhage after pancreatic and biliary surgery: embolization or surgery? Ann Surg (2005) 2.06
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg (2004) 2.01
Predictive indices of morbidity and mortality after liver resection. Ann Surg (2006) 2.01
Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg (2003) 1.88
Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg (2011) 1.81
Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg (2006) 1.57
Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg (2007) 1.45
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg (2007) 1.42
A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg (2006) 1.39
Major liver resection without a blood transfusion: is it a realistic objective? Surgery (1992) 1.27
Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg (2008) 1.27
Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg (2007) 1.19
One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome. Surgery (2005) 1.17
'Natural history' of hepatectomy. Br J Surg (1992) 1.13
Postoperative course and clinical significance of biochemical blood tests following hepatic resection. Br J Surg (2011) 1.10
Management of massive arterial hemorrhage after pancreatobiliary surgery: does embolotherapy contribute to successful outcome? J Gastrointest Surg (2007) 0.99
Circulating heat-shock protein 70 is associated with postoperative infection and organ dysfunction after liver resection. Am J Surg (2004) 0.99
Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. J Am Coll Surg (2006) 0.96
Meta-analysis of the clamp-crushing technique for transection of the parenchyma in elective hepatic resection: back to where we started? Ann Surg Oncol (2009) 0.92
Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired. Surgery (2006) 0.89
Aortic occlusion balloon catheter technique is useful for uncontrollable massive intraabdominal bleeding after hepato-pancreato-biliary surgery. J Gastrointest Surg (2006) 0.88
Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl (2006) 0.87
Liver tissue sparing resection using a novel planning tool. Langenbecks Arch Surg (2010) 0.85
Small remnant liver volume after right lobe living donor hepatectomy. Surgery (2006) 0.81
Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg (2007) 0.80
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res (2004) 18.86
The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg (2009) 16.82
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol (2008) 15.05
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med (2004) 13.34
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26
Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg (2004) 6.75
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62
Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery (2007) 6.62
Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol (2009) 5.57
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol (2009) 5.42
The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33
Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg (2013) 5.12
Colorectal cancer. Lancet (2005) 4.90
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery (2007) 4.72
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 4.34
Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med (2002) 4.25
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int (2008) 4.16
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov (2011) 3.86
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis (2011) 3.74
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet (2011) 3.54
Recalling superior mesenteric artery syndrome. Dig Surg (2007) 3.52
IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology (2002) 3.48
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 3.45
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol (2009) 3.22
Five-year results of surgical colorectal cancer treatment in rural Australia. ANZ J Surg (2013) 3.21
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15